Verona Pharma Statistics Share Statistics Verona Pharma has 84.98M
shares outstanding. The number of shares has increased by 738.45%
in one year.
Shares Outstanding 84.98M Shares Change (YoY) 738.45% Shares Change (QoQ) 0.42% Owned by Institutions (%) 10.63% Shares Floating 76.69M Failed to Deliver (FTD) Shares 26 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 4.06M, so 4.77% of the outstanding
shares have been sold short.
Short Interest 4.06M Short % of Shares Out 4.77% Short % of Float 4.97% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -21.84 and the forward
PE ratio is 118.3.
Verona Pharma's PEG ratio is
-0.11.
PE Ratio -21.84 Forward PE 118.3 PS Ratio 89.56 Forward PS 14.3 PB Ratio 18.51 P/FCF Ratio -30.84 PEG Ratio -0.11
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Verona Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 10.63,
with a Debt / Equity ratio of 0.6.
Current Ratio 10.63 Quick Ratio 10.48 Debt / Equity 0.6 Debt / EBITDA -0.86 Debt / FCF -1 Interest Coverage -6.57
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $202.29K Profits Per Employee $-829.75K Employee Count 209 Asset Turnover 0.09 Inventory Turnover 0.41
Taxes Income Tax 10.29M Effective Tax Rate -6.31%
Stock Price Statistics The stock price has increased by 326.46% in the
last 52 weeks. The beta is 0.12, so Verona Pharma's
price volatility has been higher than the market average.
Beta 0.12 52-Week Price Change 326.46% 50-Day Moving Average 96.74 200-Day Moving Average 64.98 Relative Strength Index (RSI) 69.54 Average Volume (20 Days) 3,481,474
Income Statement In the last 12 months, Verona Pharma had revenue of 42.28M
and earned -173.42M
in profits. Earnings per share was -2.16.
Revenue 42.28M Gross Profit 39.7M Operating Income -154.63M Net Income -173.42M EBITDA -142.19M EBIT -139.59M Earnings Per Share (EPS) -2.16
Full Income Statement Balance Sheet The company has 399.76M in cash and 122.7M in
debt, giving a net cash position of 277.06M.
Cash & Cash Equivalents 399.76M Total Debt 122.7M Net Cash 277.06M Retained Earnings -562.4M Total Assets 525.94M Working Capital 444.48M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -122.2M
and capital expenditures 0, giving a free cash flow of -122.78M.
Operating Cash Flow -122.2M Capital Expenditures n/a Free Cash Flow -122.78M FCF Per Share -1.51
Full Cash Flow Statement Margins Gross margin is 93.89%, with operating and profit margins of -365.73% and -410.18%.
Gross Margin 93.89% Operating Margin -365.73% Pretax Margin -385.84% Profit Margin -410.18% EBITDA Margin -336.31% EBIT Margin -365.73% FCF Margin -290.41%
